Den Europæiske Union - islandsk - EMA (European Medicines Agency)

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - stækkun Æxli, gelding-Þola - heilsueyðandi lyf - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Ónæmisbælandi lyf - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 80 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - anastrozolum inn - filmuhúðuð tafla - 1 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 20 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 50 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 5 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 25 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - lamotriginum inn - tuggu-/dreifitafla - 200 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg